Responses
Research Article
Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: immune monitoring and clinical results of a randomized phase II trial
Compose a Response to This Article
Other responses
No responses have been published for this article.